| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |